JA
Schedule 13G filing
Jennison Associates LLC disclosed a 7.7% stake in PVLA
Jennison Associates LLC reported owning 7.7% of Palvella Therapeutics, Inc. (PVLA) (1,101,652 shares) in a Schedule 13G filed Oct 28, 2026.
A 13G is a passive stake: the holder does not plan to push for changes.
- Disclosed
- Oct 28, 2026
- Source
- Schedule 13G
More PVLA insider and Congress trades
From a public Schedule 13G, linked above. Not investment advice, and not a recommendation to buy or sell.